CD1d, a sentinel molecule bridging innate and adaptive immunity, is downregulated by the human papillomavirus (HPV) E5 protein: a possible mechanism for immune evasion by HPV.
about
iNKT Cells and Their Potential Lipid Ligands during Viral InfectionRole of innate immunity against human papillomavirus (HPV) infections and effect of adjuvants in promoting specific immune responseRole of IL-10 and TGF-β1 in local immunosuppression in HPV-associated cervical neoplasiaOne protein to rule them all: modulation of cell surface receptors and molecules by HIV Nef.Evasion of host immune defenses by human papillomavirusHigh-risk human papillomavirus targets crossroads in immune signalingInnate Invariant NKT Cell Recognition of HIV-1-Infected Dendritic Cells Is an Early Detection Mechanism Targeted by Viral Immune Evasion.hrHPV E5 oncoprotein: immune evasion and related immunotherapies.Invariant NKT cell response to dengue virus infection in human.CD1d-expressing breast cancer cells modulate NKT cell-mediated antitumor immunity in a murine model of breast cancer metastasis.Cervical cancer cell lines expressing NKG2D-ligands are able to down-modulate the NKG2D receptor on NKL cells with functional implicationsInvariant NKT cells: regulation and function during viral infection.The E5 proteinsAccumulation of invariant NKT cells with increased IFN-γ production in persistent high-risk HPV-infected high-grade cervical intraepithelial neoplasia.Papillomavirus E5: the smallest oncoprotein with many functions.Hiding lipid presentation: viral interference with CD1d-restricted invariant natural killer T (iNKT) cell activationThe immune response to papillomavirus during infection persistence and regression.The invisible enemy - how human papillomaviruses avoid recognition and clearance by the host immune system.Immune regulation and evasion of Mammalian host cell immunity during viral infection.Nip the HPV encoded evil in the cancer bud: HPV reshapes TRAILs and signaling landscapesNew Approaches to Immunotherapy for HPV Associated Cancers.Viral takeover of the host ubiquitin system.The role of natural killer T cells in B cell malignancies.The role of ubiquitin and ubiquitin-like modification systems in papillomavirus biology.Natural Killer T Cells in Cancer ImmunotherapyHow Human Papillomavirus Replication and Immune Evasion Strategies Take Advantage of the Host DNA Damage Repair Machinery.Harnessing the Power of Invariant Natural Killer T Cells in Cancer Immunotherapy.CD1-Restricted T Cells During Persistent Virus Infections: "Sympathy for the Devil".Human papillomavirus-16 E5 protein: oncogenic role and therapeutic value.Epigenetic induction of CD1d expression primes lung cancer cells for killing by invariant natural killer T cellsHuman papillomavirus E5 oncoprotein: function and potential target for antiviral therapeuticsPapillomaviruses and Endocytic Trafficking
P2860
Q26800120-F2753EBB-B8F8-403A-BB51-2DF69CCB2FA6Q26996330-5F36DFCC-2A3D-4CD1-B646-00D447020B0DQ27010447-313DF0D3-AC4F-471D-93B6-A0C184A76606Q27691346-E94D8E6A-684D-4A55-941F-E962A893B907Q28076194-851199D1-B330-4BE2-BF0C-1250442B0820Q28084802-D9DF1F93-FB19-4992-86EE-9B52F2A239E3Q33390790-4DCC5D22-2675-4192-B81E-265A7A8EF9F3Q33730462-178CE417-850A-40B1-959A-5588B4D73B50Q33778714-247E70C9-FFB0-4A4E-998D-580C14666E58Q33939552-1F57FF6A-5AE3-4635-917A-97A1BE942531Q34153620-65B43A13-0108-4119-83F0-91A3879EB958Q34390484-6C399CBE-D724-41F3-85DE-B3BB14896BAEQ34754347-6E34DCAF-297F-495F-BB24-4F2520B4ECDFQ35559432-173D90C8-EE57-4F43-8DA4-832FBAFA8E9AQ35642759-60BDA14C-5111-4C77-B5A1-F5D68A7BD661Q36395876-B8650465-D20A-4586-91FF-110526AE8FB1Q36540399-8EB334B1-3DFF-46B4-A3E1-2AFFCD915E29Q36541450-C7B8D9C6-71B7-4140-B217-70E531A759AEQ36832077-36A8E564-E16B-46A0-829F-CE26D75A92D1Q36952911-FF017C81-9601-4DF7-8F99-2166C8740D0DQ37137430-9AC4791F-B946-4349-BDFA-3886DCDA8C77Q37918803-FB7B13AD-72EC-4850-92D6-EE0A23C6065BQ38090560-148C250F-EBDE-4EFC-8363-B1B707733720Q38254163-A785FA8A-8082-4E35-9A5E-B373B2960615Q42078314-6B6FF5CA-4B81-4BE0-8FAD-62C08C939D14Q47159047-EC4EB90B-57C6-42ED-B49C-61329BF04E59Q50075685-35FF5530-8FEB-4597-8330-0555ED5665A0Q52332737-A728C4CA-7439-47A3-B13E-FA02D1FDCE26Q53275556-B221EE2A-8FD8-434F-A334-0C11F8EA0064Q58143382-4668AC28-DF70-4677-8BF1-F060B5E996A0Q58420548-920C3C8F-FC1D-47DE-84CC-AE3D12268003Q58764248-13A186B6-EFE4-416E-8069-F82E4EDD132C
P2860
CD1d, a sentinel molecule bridging innate and adaptive immunity, is downregulated by the human papillomavirus (HPV) E5 protein: a possible mechanism for immune evasion by HPV.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
CD1d, a sentinel molecule brid ...... ism for immune evasion by HPV.
@ast
CD1d, a sentinel molecule brid ...... ism for immune evasion by HPV.
@en
CD1d, a sentinel molecule brid ...... ism for immune evasion by HPV.
@nl
type
label
CD1d, a sentinel molecule brid ...... ism for immune evasion by HPV.
@ast
CD1d, a sentinel molecule brid ...... ism for immune evasion by HPV.
@en
CD1d, a sentinel molecule brid ...... ism for immune evasion by HPV.
@nl
prefLabel
CD1d, a sentinel molecule brid ...... ism for immune evasion by HPV.
@ast
CD1d, a sentinel molecule brid ...... ism for immune evasion by HPV.
@en
CD1d, a sentinel molecule brid ...... ism for immune evasion by HPV.
@nl
P2093
P2860
P356
P1433
P1476
CD1d, a sentinel molecule brid ...... ism for immune evasion by HPV.
@en
P2093
Ayako Tomio
Danny J Schust
Katsuyuki Adachi
Kei Kawana
Kensuke Tomio
Satoko Kojima
Shiho Miura
Shiro Kozuma
Takeshi Nagamatsu
Terufumi Yokoyama
P2860
P304
11614-11623
P356
10.1128/JVI.01053-10
P407
P577
2010-09-01T00:00:00Z